Lisa Accomasso, Caterina Cristallini, Claudia Giachino
Abstract
The use of nanomaterials in medicine has grown very rapidly, leading to a concern about possible health risks. Surely, the application of nanotechnology in medicine has many significant potentialities as it can improve human health in at least three different ways: by contributing to early disease diagnosis, improved treatment outcomes and containment of health care costs. However, toxicology or safety assessment is an integral part of any new medical technology and the nanotechnologies are no exception. The principle aim of nanosafety studies in this frame is to enable safer design of nanomedicines. The most urgent need is finding and validating novel approaches able to extrapolate acute in vitro results for the prediction of chronic in vivo effects and to this purpose a few European initiatives have been launched. While a "safe-by-design" process may be considered as utopic, "safer-by-design" is probably a reachable goal in the field of nanomedicine.
Pharmacology, Toxicology and Pharmaceutical Science
9
10%
Medicine and Dentistry
8
9%
Engineering
5
5%
Chemical Engineering
4
4%
Other
22
23%
Unknown
32
34%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 January 2023.
All research outputs
#6,534,290
of 23,569,120 outputs
Outputs from Frontiers in Pharmacology
#2,732
of 17,186 outputs
Outputs of similar age
#114,341
of 334,487 outputs
Outputs of similar age from Frontiers in Pharmacology
#68
of 378 outputs
Altmetric has tracked 23,569,120 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 17,186 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 334,487 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.
We're also able to compare this research output to 378 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.
